Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARS: Topical Minocycline Gel in Rosacea
NCT03263273Phase 2Completed
- Sponsor
- Hovione
- Start
- Oct 2017
- Primary completion
- Mar 2019
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zilxi in papulopustular rosacea, sponsored by Hovione. Started Oct 2017; status: completed.
02
Drugs
zilxi
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT03263273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263273.